(2/2) Open to Canada-based graduate students, postdoctoral fellows, research associates, and technicians working in #StemCell and #RegenerativeMedicine. 🇨🇦
Apply today. ➡️ stemcellnetwork.ca/training/plu...
@stemcellnetwork.ca
@stemcellnetwork.ca(2/2) Open to Canada-based graduate students, postdoctoral fellows, research associates, and technicians working in #StemCell and #RegenerativeMedicine. 🇨🇦
Apply today. ➡️ stemcellnetwork.ca/training/plu...
@siisdet.bsky.social🇲🇽 Dr. Pamela Violet Rodríguez Fardoe invites you. See you in Colombia!
📩 INFORMATION & REGISTRATION
🌐 siisdet.com
📧 [email protected]
📲 WhatsApp: +57 300 741 3546
#ICPRM2026 #SIISDET #RegenerativeMedicine #CellTherapy #ScientificResearch
@alenabeauty.bsky.social🩸❤️ Кръвта е жива тъкан, която непрекъснато се обновява!
🧬 Как кръвните клетки, тромбоцитите и костният мозък участват в защитата и възстановяването на организма?
alena-beauty.com/kravta-pulsa...
#BloodHealth #RegenerativeMedicine #StemCells
@aktiego.bsky.socialHemostemix now has full Bahamian approval for its VesCell Phase 1 study, which was described as enrolling back in August while approvals were pending. Breakdown on aktiego.com.
Read more: aktiego.com/sectors/biot...
#TSXV #Biotech #CellTherapy #ClinicalTrials #BiotechNews #RegenerativeMedicine
@newsramp.comRegentis Biomaterials $RGNT reported strong surgeon interest in GelrinC at the ICRS Summit in Porto. The CE-approved hydrogel implant showed ~100% greater KOOS improvement vs. microfracture controls at 2 years. FDA pivotal trial ongoing. #RegenerativeMedicine #Orthopedics
@newsramp.comRegentis Biomaterials (RGNT) CEO Ehud Geller will present at the 2026 ThinkEquity Conference on Oct. 15, covering GelrinC technology, FDA Phase III progress, and European commercialization plans. One-on-one investor meetings also available. #RegenerativeMedicine #Biotech
@glf-2026.bsky.socialAdvancing the Future of Longevity Science!
Discover innovations in personalized medicine and healthy aging at GLF 2027, the Global Longevity Federation!
Feb 10–11, 2027 | Miami & Online
🌐 longevityfederation.com
#LongevityScience #HealthyAging #RegenerativeMedicine #AgingResearch
@sepianano.bsky.social🧬DNA fragments derived from salmon sperm, originally explored in regenerative medicine for their role in tissue repair, have now found their way into one of skincare’s biggest trends.
So, how did we get here?
⬇️Find out below
The Culture Edit x SepiaNano
@siisdet.bsky.social🌎 Medellín, Colombia | Nov. 25–28, 2026. ICPRM© 2026 – SIISDET®: Science, innovation, and global leadership in regenerative medicine and pain management. Research, international experts, advanced technologies, and multidisciplinary collaboration.
#ICPRM2026 #SIISDET #RegenerativeMedicine
@newsramp.comRegentis Biomaterials' GelrinC hydrogel implant showed ~100% greater KOOS improvement vs. microfracture in Phase II trials. A U.S. pivotal trial targets completion by end of 2026, targeting 470,000 annual knee cartilage cases with no current off-the-shelf fix. #Orthopedics #RegenerativeMedicine
@siisdet.bsky.socialMSK REGENERATIVE MEDICINE | Advanced Biologic Therapies for Musculoskeletal Injuries. PRP, stem cells, BMAC, exosomes, microfat & emerging regenerative strategies focused on evidence-based clinical practice. 📩 [email protected] | +57 300 741 3546
#RegenerativeMedicine #30thISRM2026
@siisdet.bsky.social30th ISRM© 2026 | From Myths to Evidence: Interventional Regenerative Medicine. Advanced science, clinical innovation & global expertise. Nov 27 | Medellín, Colombia. Organized by SIISDET®.
#ISRM2026 #RegenerativeMedicine
@siisdet.bsky.social15th ICPRM© 2026 | ADVANCED SCIENTIFIC SESSION
Regeneration & Advanced Biostimulation in Aesthetic Medicine. From infection control to tissue regeneration.
📅 Nov 26, 2026 | 10:30–11:42 AM
📍 Medellín, Colombia
Organized by SIISDET®.
@newsramp.comRegentis Biomaterials CEO discusses GelrinC progress on the BioMedWire Podcast — EU-approved, U.S. pivotal trial enrollment nearing completion, targeting 470,000 untreated knee cartilage cases annually. #RegenerativeMedicine #RGNT
@newsramp.comTreVita expands its regenerative medicine program in Baja California, offering stem cell services across aging, rejuvenation, and orthopedic recovery with a focus on transparency, physician oversight, and individualized care. The U.S. market is projected to hit $49.3B by 2030. #RegenerativeMedicine
@newsramp.comTreVita expands its regenerative medicine program in Baja California, offering stem cell services across aging, rejuvenation, and orthopedic recovery with a focus on transparency, physician oversight, and individualized care. The U.S. market is projected to hit $49.3B by 2030. #RegenerativeMedicine
@glf-2026.bsky.socialCall for Abstracts | #GLF2027
Researchers & scientists, share your work in longevity and healthy aging!
February 10–11, 2027 | 📍 Miami, USA
🔗 Submit now: longevityfederation.com/abstract-sub...
#LongevityResearch #HealthyAging #Gerontology #RegenerativeMedicine #Biotechnology
@oddlytruejp.bsky.social🧠 Japan approved a stem cell therapy for brain injury in 2024. Its first commercial use came only last week.
A man paralyzed in a car crash had donor cells injected into his brain in Sapporo. Price: ¥72.7M (~$460K) per dose.
@coherentcmi.bsky.socialBiomedical Materials Market Size, Trends, and Growth Prospects 2026-2033
www.coherentcmi.com/industry-rep...
#BiocompatibleMaterials #BiomedicalEngineering #MedicalDevices #HealthcareTechnology #RegenerativeMedicine #TissueEngineering
@robertcfried.bsky.social